| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |